Evidence map›Paper›PMID 31691806›Full record

ArticleHuman molecular genetics2019

Histone demethylase KDM5C is a SAHA-sensitive central hub at the crossroads of transcriptional axes involved in multiple neurodevelopmental disorders.

Loredana Poeta, Agnese Padula, Benedetta Attianese, Mariaelena Valentino, Lucia Verrillo, Stefania Filosa, Cheryl Shoubridge, Adriano Barra, Charles E Schwartz, Jesper Christensen and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Identification of Novel Co-OccurringThe application of clinical genetics · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The Chromatin-Oxygen Sensor GeneInternational journal of molecular sciences · 2022
    Article
  15. Article
  16. Further Delineation of Duplications ofInternational journal of molecular sciences · 2022
    Review
  17. Reprogramming of the epigenome in neurodevelopmental disorders.Critical reviews in biochemistry and molecular biology · 2022
    Review
  18. Astroglia in Autism Spectrum Disorder.International journal of molecular sciences · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 6 countries.

Loredana PoetaInstitute of Genetics and Biophysics "Adriano Buzzati-Traverso", National Research Council (CNR), Naples, Italy.
Agnese PadulaInstitute of Genetics and Biophysics "Adriano Buzzati-Traverso", National Research Council (CNR), Naples, Italy.
Benedetta AttianeseInstitute of Genetics and Biophysics "Adriano Buzzati-Traverso", National Research Council (CNR), Naples, Italy.
Mariaelena ValentinoInstitute of Genetics and Biophysics "Adriano Buzzati-Traverso", National Research Council (CNR), Naples, Italy.
Lucia VerrilloInstitute of Genetics and Biophysics "Adriano Buzzati-Traverso", National Research Council (CNR), Naples, Italy.
Stefania FilosaInstitute of Biosciences and BioResources, National Research Council (CNR), Naples, Italy.
Cheryl ShoubridgeIntellectual Disability Research, Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
Adriano BarraInstitute of Genetics and Biophysics "Adriano Buzzati-Traverso", National Research Council (CNR), Naples, Italy.
Charles E SchwartzGreenwood Genetics Center, Greenwood, United States.
Jesper ChristensenUniversity of Copenhagen, Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark.
Hans van BokhovenDepartment of Human Genetics, Donders Institute for Brain, Behaviour and Cognition, Radboudumc, Nijmegen, The Netherlands.
Kristian HelinUniversity of Copenhagen, Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark.
Maria Brigida LioiDepartment of Science, University of Basilicata, Potenza, Italy.
Patrick CollombatUniversité Côte d'Azur, CNRS, Inserm, iBV, Nice, France.
Jozef GeczFaculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia.
Lucia AltucciUniversity of Campania Luigi Vanvitelli, Caserta, Italy.
Elia Di SchiaviInstitute of Biosciences and BioResources, National Research Council (CNR), Naples, Italy.
Maria Giuseppina MianoInstitute of Genetics and Biophysics "Adriano Buzzati-Traverso", National Research Council (CNR), Naples, Italy.
National Research Council · ITInstitute of Genetics and Biophysics · ITUniversity of Adelaide · AUGreenwood Genetic Center · USInstitute of Biosciences and Bioresources · ITIstituto Neurologico Mediterraneo · ITNovo Nordisk Foundation · DKRadboud University Nijmegen · NLUniversité Côte d'Azur · FRUniversity of Basilicata · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Copenhagen · DK

Funding

X-LINKED MENTAL RETARDATION: LINKAGE &CLINICAL STUDIESR01HD026202 · NICHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCHWARTZ, CHARLES E · 1990 to 2006
$7.9M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
NICHD NIH HHS R01 HD026202NIH HHS P40 OD010440
6 · The paper itself

Abstract

A disproportional large number of neurodevelopmental disorders (NDDs) is caused by variants in genes encoding transcription factors and chromatin modifiers. However, the functional interactions between the corresponding proteins are only partly known. Here, we show that KDM5C, encoding a H3K4 demethylase, is at the intersection of transcriptional axes under the control of three regulatory proteins ARX, ZNF711 and PHF8. Interestingly, mutations in all four genes (KDM5C, ARX, ZNF711 and PHF8) are associated with X-linked NDDs comprising intellectual disability as a core feature. in vitro analysis of the KDM5C promoter revealed that ARX and ZNF711 function as antagonist transcription factors that activate KDM5C expression and compete for the recruitment of PHF8. Functional analysis of mutations in these genes showed a correlation between phenotype severity and the reduction in KDM5C transcriptional activity. The KDM5C decrease was associated with a lack of repression of downstream target genes Scn2a, Syn1 and Bdnf in the embryonic brain of Arx-null mice. Aiming to correct the faulty expression of KDM5C, we studied the effect of the FDA-approved histone deacetylase inhibitor suberanilohydroxamic acid (SAHA). In Arx-KO murine ES-derived neurons, SAHA was able to rescue KDM5C depletion, recover H3K4me3 signalling and improve neuronal differentiation. Indeed, in ARX/alr-1-deficient Caenorhabditis elegans animals, SAHA was shown to counteract the defective KDM5C/rbr-2-H3K4me3 signalling, recover abnormal behavioural phenotype and ameliorate neuronal maturation. Overall, our studies indicate that KDM5C is a conserved and druggable effector molecule across a number of NDDs for whom the use of SAHA may be considered a potential therapeutic strategy.

Indexed as

AnimalsCaenorhabditis elegansCell LineDNA-Binding ProteinsFemaleHEK293 CellsHistone Deacetylase InhibitorsHistone DemethylasesHistonesHomeodomain ProteinsHumansMaleMethylationMiceMice, Inbred C57BLMice, KnockoutARX protein, humanDNA-Binding ProteinsHistone Deacetylase InhibitorsHistone Demethylaseshistone H3 trimethyl Lys4HistonesHomeodomain ProteinsKDM5C protein, humanPHF8 protein, humanTranscription FactorsVorinostatZNF711 protein, human

Identifiers

PMID31691806
PMCPMC7002875
OpenAlexW2983368623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.